Publication

( * : equal contribution, # : corresponding author)

2021年

  • Kentaro Okada *, Shogo Tamura *, #, Nobuaki Suzuki, Koya Odaira, Masato Mukaide, Wataru Fujii, Yumi Katsuragi, Atsuo Suzuki, Takeshi Kanematsu, Shuichi Okamoto, Naruko Suzuki, Akira Katsumi, Tadashi Matsushita, Tetsuhito Kojima, Fumihiko Hayakawa. 2021. "Protein S-Leu17Pro disrupts the hydrophobicity of its signal peptide causing a proteasome-dependent degradation." Thrombosis Research. In press.
  • Akira Katsumi, Akihiro Abe, Shogo Tamura, Tadashi Matsushita. 2021. "Anemia in older adults as a geriatric syndrome: A review".  Geriatrics and Gerontology International. 21(7): 549-554. DOI: 10.1111/ggi.14183
  • Shimon Otake, Tomoyuki Sasaki, Toshiaki Shirai, Nagaharu Tsukiji, Shogo Tamura, Katsuhiro Takano, Yukio Ozaki, Katsue Suzuki-Inoue. 2021. "CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice". Journal of Thrombosis and Haemostasis. 19(6): 1572-1584. doi:10.1111/jth.15317
  • Yuri Hayakawa, Shogo Tamura #, Nobuaki Suzuki, Koya Odaira, Mahiru Tokoro, Fumika Kawashima, Fumihiko Hayakawa, Akira Takagi, Akira Katsumi, Atsuo Suzuki, Shuichi Okamoto, Takeshi Kanematsu, Tadashi Matsushita, and Tetsuhito Kojima. 2021. "Essential role of a carboxyl-terminal α-helix motif in the secretion of coagulation factor XI". Journal of Thrombosis and Haemostasis. 19(4): 920-930. DOI: 10.1111/jth.15242
  • Takeshi Kanematsu, Nobuaki Suzuki, Shogo Tamura, Atsuo Suzuki, Yuichi Ishikawa, Akira Katsumi, Hitoshi Kiyoi, Hidehiko Saito, Shinji Kunishima, Tetsuhito Kojima, Tadashi Matsushita. 2021. "Myh9 R702C is associated with erythroid abnormality with splenomegaly in mice". Nagoya Journal of Medical Science. 83. 75–86. doi:10.18999/nagjms.83.1.75
  • Atsuo Suzuki, Nobuaki Suzuki, Takeshi Kanematsu, Shuichi Okamoto, Shogo Tamura, Ryosuke Kikuchi, Akira Katsumi, Hitoshi Kiyoi, Tetsuhito Kojima, Tadashi Matsushita. 2020. "Impact of variation in reagent combinations for one‐stage clotting assay on assay discrepancy in nonsevere haemophilia A". International journal of laboratory hematology. 43(1): 131-138.  https://doi.org/10.1111/ijlh.13335

 

2020年

  • 鈴木敦夫，鈴木伸明，兼松 毅，岡本修一，田村彰吾，篠原 翔， 新井信夫，菊地良介，安藤善孝，小嶋哲人，松下 正. 2020.  "血小板膜糖蛋白質GPIb変異体を用いたvon Willebrand因子 活性測定試薬「INNOVANCE® VWF Ac」の基本性能評価". 日本血栓止血学会誌 31(4): 409-419. https://doi.org/10.2491/jjsth.31.409
  • Tokoro M *, Tamura S *,  #, Suzuki N, Kakihara M, Hattori Y, Odaira K, Suzuki S, Takagi A, Katsumi A, Hayakawa F, Okamoto S, Suzuki A, Kanematsu T, Matsushita T, Kojima T. 2020. "Aberrant X chromosomal rearrangement through multi-step template switching during sister chromatid formation in a patient with severe hemophilia A". Molecular Genetics and Genomic Medicine 8(9) e1390. https://doi.org/10.1002/mgg3.1390
  • 田村彰吾 #、高木明、早川文彦、小嶋哲人. 2020. “先天性凝固異常症の遺伝子解析 「解析のStrategyとPitfall」” 日本検査血液学会雑誌 21 (1): 71–80.
  • Ogawa M, Suzuki N, Takahashi N, Tamura S, Suzuki A, Suzuki S, Hattori Y, Kakihara M, Kanematsu, T, Kojima, Toshihisa, Katsumi A, Hayakawa F, Kojima Tetsuhito, Ishiguro N, Kiyoi H, Matsushita T. 2020. “Higher FVIII:C Measured by Chromogenic Substrate Assay than by One-Stage Assay Is Associated with Silent Hemophilic Arthropathy.” Thrombosis Research 188 (January): 103–5. DOI: 10.1016/j.thromres.2020.01.003

2019年

  • Inoue O, Osada M, Nakamura J, Kazama F, Shirai T, Tsukiji N, Sasaki T, Yokomichi H, Dohi T, Kaneko M, Kurano M, Oosawa M, Tamura S, Satoh K, Takano K, Miyauchi K, Daida H, Yatomi Y, Ozaki Y, Suzuki-Inoue K. 2019. “Soluble CLEC-2 Is Generated Independently of ADAM10 and Is Increased in Plasma in Acute Coronary Syndrome: Comparison with Soluble GPVI.” International Journal of Hematology 110(3):285-294. https://doi.org/10.1007/s12185-019-02680-4.
  • Tamura S *, #, Hashimoto E *, Suzuki N, Kakihara M, Odaira K, Hattori Y, Tokoro M, Sachiko S, Takagi A, Katsumi A, Hayakawa F, Suzuki A, Okamoto S, Kanematsu T, Matsushita T, Kojima T. 2019. “Molecular Basis of SERPINC1 Mutations in Japanese Patients with Antithrombin Deficiency.” Thrombosis Research 178 (April): 159–70. DOI: 10.1016/j.thromres.2019.04.004.
  • Odaira K *, Tamura S *, #, Suzuki N, Kakihara M, Hattori Y, Tokoro M, Suzuki S, Takagi A, Katsumi A, Hayakawa F, Okamoto S, Suzuki A, Kanematsu T, Matsushita T, Kojima T. 2019. “Apparent Synonymous Mutation F9 c.87A>G Causes Secretion Failure by in-Frame Mutation with Aberrant Splicing.” Thrombosis Research 179 (April): 95–103.  DOI: 10.1016/j.thromres.2019.04.022.
  • Okamoto S,  Suzuki N, Suzuki A, Suzuki S, Tamura S, Suzuki M, Takahashi N, Kojima Toshihisa, Kanematsu T, Kojima, Tetsuhito, Kiyoi H, Ishiguro N, Matsushita T. 2019. “Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors.” TH Open 3 (4): e364–66.  DOI: 10.1055/s-0039-3401001.
  • Tamura S, Suzuki-Inoue K, Ozaki Y, Hayakawa F, Kojima T. 2019. “[Peri-Arteriolar Megakaryopoietic Microenvironment via Reciprocal CLEC-2/PDPN Axis in Bone Marrow].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 60 (7): 834–42.  DOI: 10.11406/rinketsu.60.834.

2018年

  • 田村彰吾 #. 2018. “マウス骨髄の Podoplanin 陽性傍細動脈間質細胞は CLEC-2 を介して巨核球系細胞の増殖と Proplatelet Formation を促進する.” 日本血栓止血学会誌 29 (4): 389–97.  DOI: 10.2491/jjsth.29.389.
  • Tsukiji N, Inoue O, Morimoto M, Tatsumi N, Nagatomo H, Ueta K, Shirai T, Sasaki T, Otake S, Tamura S, Tachibana T, Okabe M, Hirashima M, Ozaki Y, Suzuki-Inoue K. 2018. “Platelets Play an Essential Role in Murine Lung Development through Clec-2/Podoplanin Interaction.” Blood 132 (11): 1167–79.  DOI: 10.1182/blood-2017-12-823369.
  • Sasaki T, Shirai T, Tsukiji N, Otake S, Tamura S, Ichikawa J, Osada M, Satoh K, Ozaki Y, Suzuki-Inoue K. 2018. “Functional Characterization of Recombinant Snake Venom Rhodocytin: Rhodocytin Mutant Blocks CLEC-2/Podoplanin-Dependent Platelet Aggregation and Lung Metastasis.” Journal of Thrombosis and Haemostasis 16 (5): 960–72.  DOI: 10.1111/jth.13987.
  • Tamura S, Suga Y, Tanamura M, Murata-Kawakami M, Takagi Y, Hottori Y, Kakihara M, Suzuki S, Takagi A, Kojima T. 2018. “Optimisation of Antithrombin Resistance Assay as a Practical Clinical Laboratory Test: Development of Prothrombin Activator Using Factors Xa/Va and Automation of Assay.” International Journal of Laboratory Hematology 40 (3): 312–19.  DOI: 10.1111/ijlh.12786.
  • Suzuki S, Nakamura Y, Suzuki N, Yamazaki T, Takagi Y, Tamura S, Takagi A, Kanematsu T, Matsushita T, Kojima T. 2018. “Combined Deficiency of Factors V and VIII by Chance Coinheritance of Parahaemophilia and Haemophilia A, but Not by Mutations of Either LMAN1 or MCFD2, in a Japanese Family.” Haemophilia 24 (1): e13–16.  DOI: 10.1111/hae.13360. 
  • 高木明、田村彰吾、小嶋哲人. 2018. "アンチトロンビン抵抗性の診断 - 検査法を中心に -". 日本検査血液学会雑誌 19(3): 393-400. 

 

2017年

  • Kamiyama M, Shirai T, Tamura S, Suzuki-Inoue K, Ehata S, Takahashi K, Miyazono K, Hayakawa Y,

    Sato T, Takeda K, Naguro I, Ichijo H. 2017. “ASK1 Facilitates Tumor Metastasis through Phosphorylation of an ADP Receptor P2Y12 in Platelets.” Cell Death and Differentiation 24 (12): 2066–76.  DOI: 10.1038/cdd.2017.114.

  • Furuya F, Ishii T, Tamura S, Takahashi, Kobayashi H, Ichijo M, Takizawa S, Kaneshige M, Suzuki-Inoue K, and Kitamura K. 2017. “The Ligand-Bound Thyroid Hormone Receptor in Macrophages Ameliorates Kidney Injury via Inhibition of Nuclear Factor-ΚB Activities.” Scientific Reports 7 (March): 43960.  DOI: 10.1038/srep43960.
  • 田村彰吾 #、尾崎由基男、小嶋哲人、井上克枝. 2017. “血小板・巨核球造血微小環境を構成する骨髄間質細胞.” 日本血栓止血学会誌 28 (1): 59–63. DOI: https://doi.org/10.2491/jjsth.28.59.
  • Tamura S, Murata-Kawakami M, Takagi Y, Suzuki S, Katsumi A, Takagi A, Kojima T. 2017. “In Vitro Exploration of Latent Prothrombin Mutants Conveying Antithrombin Resistance.” Thrombosis Research 159 (August): 33–38.  DOI: 10.1016/j.thromres.2017.09.020.
  • 田村彰吾 #、井上克枝、小嶋哲人. 2017. “２．巨核球造血の微小環境.” 血液フロンティア 27 (6): 37–46.
  • Shirai T,  Inoue O, Tamura S, Tsukiji N, Sasaki T, Endo H, Satoh K, Osada M, Sato-Uchida H, Fujii H,  Ozaki Y, Suzuki-Inoue K. 2016. “CLEC-2 Promotes Hematogenous Tumor Metastasis and Prothrombotic State in Tumor-Bearing Mice.” Journal of Thrombosis and Haemostasis 38 (1): 42–49.  DOI: 10.1111/jth.13604.

2016年

  • Ozaki Y, Tamura S, Suzuki-Inoue K. 2016. “New Horizon in Platelet Function: With Special Reference to a Recently-Found Molecule, CLEC-2.” Thrombosis Journal 14 (Suppl 1): 27.  DOI: 10.1186/s12959-016-0099-8.
  • Takagi Y, Murata M, Kozuka T, Nakata Y, Hasebe R, Tamura S, Takagi A, Matsushita T, Saito H, Kojima T. 2016. “Missense Mutations in the Gene Encoding Prothrombin Corresponding to Arg596 Cause Antithrombin Resistance and Thrombomodulin Resistance.” Thrombosis and Haemostasis 116 (6): 1–10.  DOI: 10.1160/TH16-03-0223.
  • Kozuka T, Tamura S, Kawamura N, Nakata Y, Hasebe R, Makiyama A, Takagi Y, Murata M, Mizutani N, Takagi A, Kojima T. 2016. “Progestin Isoforms Provide Different Levels of Protein S Expression in HepG2 Cells.” Thrombosis Research 145 (September): 40–45.  DOI: 10.1016/j.thromres.2016.07.007.
  • Tamura S, Suzuki-Inoue K, Tsukiji N, Shirai T, Sasaki T, Osada M, Satoh K, Ozaki Y. 2016. “Podoplanin-Positive Periarteriolar Stromal Cells Promote Megakaryocyte Growth and Proplatelet Formation in Mice by CLEC-2.” Blood 127 (13): 1701–10.  DOI: 10.1182/blood-2015-08-663708.

～ 2015年

  • Masuda Y*, Tamura S*, Matsuno K, Nagasawa A, Hayasaka K, Shimizu C, Moriyama T. 2015. “Diverse CD36 Expression among Japanese Population: Defective CD36 Mutations Cause Platelet and Monocyte CD36 Reductions in Not Only Deficient but Also Normal Phenotype Subjects.” Thrombosis Research 135 (5): 951–57.  DOI: 10.1016/j.thromres.2015.03.002.
  • Kazama F, Nakamura N, Osada M, Inoue O, Oosawa M, Tamura S, Tsukiji N, Aida K, Kawaguchi A, 

    Takizawa S, Kaneshige M, Tanaka S, Suzuki-Inoue K,Ozaki Y. 2015. “Measurement of Soluble C-Type Lectin-like Receptor 2 in Human Plasma.” Platelets 26 (8): 711–19.  DOI: 10.3109/09537104.2015.1021319.

  • Moriyama T, Tamura S, Nakano K, Otsuka K, Shigemura M, Honma N. 2015. “Laboratory and Clinical Features of Abnormal Macroenzymes Found in Human Sera.” Biochimica et Biophysica Acta 1854 (6): 658–67.  DOI: 10.1016/j.bbapap.2014.10.015.
  • Nagasawa, A, K Matsuno, S Tamura, K Hayasaka, C Shimizu, and T Moriyama. 2013. “The Basis Examination of Leukocyte-Platelet Aggregates with CD45 Gating as a Novel Platelet Activation Marker.” International Journal of Laboratory Hematology 35 (5): 534–41.  DOI: 10.1111/ijlh.12051.
  • Nakano K, Tamura S, Otuka K, Niizeki N, Shigemura N, Shimizu C, Matsuno K, Kobayashi S, Moriyama T. 2013. “Development of a Highly Sensitive Three-Dimensional Gel Electrophoresis Method for Characterization of Monoclonal Protein Heterogeneity.” Analytical Biochemistry 438 (2): 117–23.  DOI: 10.1016/j.ab.2013.03.013.
  • Nozaki R, Tamura S, Ito A, Moriyama T, Yamaguchi K, Kono T. 2012. “A Rapid Method to Isolate Soluble Royal Jelly Proteins.” Food Chemistry 134 (4): 2332–37.  DOI: 10.1016/j.foodchem.2012.03.106.
  • Tamura S, Nagasawa A, Masuda Y, Tsunematsu T, Hayasaka K, Matsuno M, Shimizu C, Ozaki O, Moriyama T. 2012. “BDNF, Produced by a TPO-Stimulated Megakaryocytic Cell Line, Regulates Autocrine Proliferation.” Biochemical and Biophysical Research Communications 427 (3): 542–46.  DOI: 10.1016/j.bbrc.2012.09.093.
  • Tamura S, Suzuki H, Hirowatari Y, Hatase M, Nagasawa A, Matsuno K, Kobayashi S, Moriyama T. 2011. “Release Reaction of Brain-Derived Neurotrophic Factor (BDNF) through PAR1 Activation and Its Two Distinct Pools in Human Platelets.” Thrombosis Research 128 (5): e55-61.  DOI: 10.1016/j.thromres.2011.06.002.
  • Tamura S, Amano S, Kono K, Kondoh J, Yamaguchi K, Kobayashi S, Ayabe T, Moriyama T. 2009. “Molecular Characteristics and Physiological Functions of Major Royal Jelly Protein 1 Oligomer.” Proteomics 9 (24): 5534–43.  DOI: 10.1002/pmic.200900541.
  • Tamura S, Kono T, Harada C, Yamaguchi K, Moriyama T. 2009. “Estimation and Characterisation of Major Royal Jelly Proteins Obtained from the Honeybee Apis Merifera.” Food Chemistry 114 (4): 1491–97.  DOI: 10.1016/j.foodchem.2008.11.058.